Baird Melissa's Form 4 filing
Hims & Hers Health, Inc. (HIMS) · filed Nov 19, 2024
- Accession no.
- 0001773751-24-000365
- Filed
- Nov 19, 2024, 6:08 PM ET
- Trade date
- Nov 18, 2024
- Filing delay
- 1 day
- Rule 10b5-1 plan
- Checked
This filing lists 5 non-derivative transactions and 1 derivative transaction. Open-market sales total $1.24M. It was filed 1 day after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Baird MelissaCIK 0001837815 | Officer (Chief Operating Officer) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Nov 18, 2024 | Class A Common Stock | MOption exerciseAcquired | +58,750 | $0.40 | +$23,500 | 688,916 | Direct | |
| Nov 18, 2024 | Class A Common Stock | SSaleDisposed | −6,199 | $20.60F2 | −$127,729.16 | 682,717 | Direct | |
| Nov 18, 2024 | Class A Common Stock | SSaleDisposed | −11,426 | $21.30F3 | −$243,403.51 | 671,291 | Direct | |
| Nov 18, 2024 | Class A Common Stock | SSaleDisposed | −12,601 | $20.48F4 | −$258,094.94 | 658,690 | Direct | |
| Nov 18, 2024 | Class A Common Stock | SSaleDisposed | −28,524 | $21.29F5 | −$607,136.19 | 630,166 | Direct |
Derivative securities (Table II)
Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.
| Trade date | Security | Transaction | Underlying shares | Unit price | Value | Held after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Nov 18, 2024 | Class A Common Stock | MOption exerciseDisposed | −58,750 | $0.00 | $0 | 343,178 | Direct |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
- F2
Price reported constitutes the average weighted price of shares sold. Shares were sold at varying prices in the range of $19.97 - $20.965. The Reporting Person hereby undertakes, upon request of the Commission, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price.
Referenced by the price of 1 transaction in Table I.
- F3
Price reported constitutes the average weighted price of shares sold. Shares were sold at varying prices in the range of $20.98 - $21.76. The Reporting Person hereby undertakes, upon request of the Commission, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price.
Referenced by the price of 1 transaction in Table I.
- F4
Price reported constitutes the average weighted price of shares sold. Shares were sold at varying prices in the range of $19.89 - 20.885. The Reporting Person hereby undertakes, upon request of the Commission, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price.
Referenced by the price of 1 transaction in Table I.
- F5
Price reported constitutes the average weighted price of shares sold. Shares were sold at varying prices in the range of $20.905 - $21.825. The Reporting Person hereby undertakes, upon request of the Commission, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price.
Referenced by the price of 1 transaction in Table I.